Future directions in the management of soft tissue sarcomas

Hematol Oncol. 1992 Jan-Feb;10(1):53-60. doi: 10.1002/hon.2900100110.

Author

A D Elias¹

Affiliation

¹ Division of Clinical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.

PMID: 1563704
DOI: 10.1002/hon.2900100110

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Forecasting
Humans
Neoplasm Staging
Sarcoma / diagnosis
Sarcoma / drug therapy
Sarcoma / therapy*